Skip to main content
. 2023 Sep 14;23:182. doi: 10.1186/s12911-023-02283-4

Table 1.

Patients’ characteristics on baseline

Characteristics Telemedicine(212) Control(206) p value*
Age (years) 52.1 ± 9.2 51.8 ± 8.3 0.68
Males (%) 62(45.5) 48(47.5) 0.85
Diabetes duration (years) 7.4 ± 1.5 7.2 ± 1.5 0.46
FBG (mmol/L) 7.1 ± 1.6 7.0 ± 1.6 0.75
2hPBG (mmol/L) 9.7 ± 2.3 9.6 ± 2.2 0.69
HbA1c (%) 7.9 ± 0.9 8.0 ± 0.9 0.56
BMI (Kg/m2) 24.6 ± 1.9 24.2 ± 1.5 0.18
Systolic BP (mmHg) 125.4 ± 13.3 125.5 ± 13.9 0.95
Diastolic BP (mmHg) 76.6 ± 9.1 77.17 ± 10.8 0.84
Triglycerides (mmol/L) 2.4 ± 0.8 2.6 ± 1.0 0.40
Total cholesterol (mmol/L) 5.4 ± 0.7 5.5 ± 0.8 0.91
HDL cholesterol (mmol/L) 1.1 ± 0.4 1.1 ± 0.3 0.95
LDL cholesterol (mmol/L) 3.7 ± 0.7 3.8 ± 0.8 0.79
Glucose control methods
OAD only 97(0.71) 78(0.77) 0.64
Insulin only 2(0.01) 1(0.01) 0.51
OAD + insulin 38(0.28) 22(0.22) 0.48
Educational status
Elementary 34(25) 26(25.7) 0.55
Middle 73(53.6) 56(55.4) 0.68
High 27(19.8) 18(17.8) 0.29
College 2(1.4) 1(0.9) 0.17

Testing

frequency(times/month)

1.9 ± 0.3 1.7 ± 0.6 0.86

Data are means ± SD or n (%). FBG, fasting blood glucose; BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; OAD, oral hypoglycemic drugs

*P<0.05